Financials
- Market Capitalization 13.49 M
- Employee 18
- Founded 2016
- CEO N/A
- Website www.in8bio.com
- Headquarter Delaware, United States
- FIGI BBG00XX9K1M2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.53
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4751 | INTS Intensity Therapeutics, Inc. - Common Stock | 4.80 USD | -2.44% | -0.21% | +31.15% | +1354.55% | 12.97 M USD | ||
| 4752 | COCP Cocrystal Pharma, Inc. - Common Stock | 0.97 USD | +1.04% | -3.96% | -2.02% | -43.60% | 13.37 M USD | ||
| 4759 | GTBP GT Biopharma, Inc. - Common Stock | 0.36 USD | -7.69% | -21.74% | -25.00% | -83.18% | 12.98 M USD | ||
| 4765 | LNAI Lunai Bioworks Inc. - Common Stock | 2.82 USD | -0.35% | +1.08% | +16.05% | +81.94% | 12.79 M USD |